Previous 10 | Next 10 |
Evoke Pharma (NASDAQ: EVOK ) +85% on FDA approval . More news on: Evoke Pharma, Inc., Theratechnologies Inc., Broadway Financial Corporation, Stocks on the move, , Read more ...
Merger activity decreased last week with two new deals announced, and one deal closing. One of the two new deals announced last week was on our list of potential deals and the other one was a "going private" transaction. According to Reuters, Australian antitrust regulators expressed conc...
The bidding competition for Tetraphase Pharmaceuticals (NASDAQ: TTPH ) is not over yet. La Jolla Pharmaceutical (NASDAQ: LJPC ) has submitted an unsolicited bid of $43.0M in cash plus an additional $16.0 payable under contingent value rights (CVRs). More news on: Tetraphase Pharmaceutica...
Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline XERAVA TM (eravacycline for injection) to treat serious and life-threatening infections, today announced that on June 19, 2020, its Board of Directors received an uns...
After just one new deal announced in the prior four weeks, merger activity increased last week with three new deals announced, three deals closing, and one suitor attempting to walk away from a deal. Simon Property Group ( SPG ) attempted to walk away from its acquisition of Taubman Centers ...
Gainers: LAKE +32.9% . DUO +27.5% . TTPH +17.6% . FIVE +10.6% . APT +10.5% . More news on: Lakeland Industries, Inc., Fangdd Network Group Ltd., Tetraphase Pharmaceuticals, Inc., Stocks on the move, , Read more ...
Emerging victorious in a bidding joust with AcelRx Pharmaceuticals (NASDAQ: ACRX ), Melinta Therapeutics (NASDAQ: MLNT ) enters into a definitive merger agreement with Tetraphase Pharmaceuticals (NASDAQ: TTPH ) under which it will acquire the company for $39M in cash plus an additional $16...
Merger activity increased last week with one new deal announced, three deals closing and two deals called off. While two terminated deals in one week is a lot, the news was not all bad as one of those terminations was because the company received a better offer. Just when we thought the bidd...
Opiant Pharmaceuticals (NASDAQ: OPNT ) -32% after Teva prevails in Narcan patent dispute . More news on: Opiant Pharmaceuticals, Inc., Ascena Retail Group, Inc., Ekso Bionics Holdings, Inc., Stocks on the move, , Read more ...
Hertz Global (NYSE: HTZ ) +84% on bullish travel updates . More news on: Hertz Global Holdings, Inc., QEP Resources, Inc., Dynagas LNG Partners LP, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Tetraphase Pharmaceuticals Inc. Company Name:
TTPH Stock Symbol:
NASDAQ Market:
Tetraphase Pharmaceuticals Inc. Website:
SAN DIEGO, California and WATERTOWN, Massachusetts, July 28, 2020 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening disease...
La Jolla agreement provides for $43.0 million in upfront cash plus potential future cash payments of up to $16.0 million pursuant to contingent value rights Combined company will offer two innovative therapies to treat patients suffering from life-threatening diseases SAN DIEGO, Ca...
Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline XERAVA TM (eravacycline for injection) to treat serious and life-threatening infections, today announced that on June 19, 2020, its Board of Directors received an uns...